Global Tinea Pedis Treatment Market Size, Status and Forecast 2025

Publisher Name :
Date: 13-Apr-2018
No. of pages: 112
Inquire Before Buying

This report studies the global Tinea Pedis Treatment market, analyzes and researches the Tinea Pedis Treatment development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like

- GSK

- Exeltis USA

- Promius Pharma

- Valeant

- Incyte

- Polichem

- Viamet Pharmaceuticals

- Aqua Pharmaceuticals

- Theravance Biopharma

- Bristol-Myers Squibb

- Celgene

- Hexima

- Hisamitsu Pharmaceutical

- Dermira

- NovaBiotics

- Elorac

- F. Hoffmann-La Roche

- Galderma

- Mayne Pharma

- Sanofi

- Teva Pharmaceutical

Market segment by Regions/Countries, this report covers

- United States

- EU

- Japan

- China

- India

- Southeast Asia

Market segment by Type, the product can be split into

- Antifungals

- Steroids and Anti-Infective Combinations

Market segment by Application, Tinea Pedis Treatment can be split into

- Hospital Pharmacies

- Retail Pharmacies

- Online Pharmacies

- Drug Stores

- Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Global Tinea Pedis Treatment Market Size, Status and Forecast 2025

Table of Contents
Global Tinea Pedis Treatment Market Size, Status and Forecast 2025
1 Industry Overview of Tinea Pedis Treatment
1.1 Tinea Pedis Treatment Market Overview
1.1.1 Tinea Pedis Treatment Product Scope
1.1.2 Market Status and Outlook
1.2 Global Tinea Pedis Treatment Market Size and Analysis by Regions (2013-2018)
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Tinea Pedis Treatment Market by Type
1.3.1 Antifungals
1.3.2 Steroids and Anti-Infective Combinations
1.4 Tinea Pedis Treatment Market by End Users/Application
1.4.1 Hospital Pharmacies
1.4.2 Retail Pharmacies
1.4.3 Online Pharmacies
1.4.4 Drug Stores
1.4.5 Other
2 Global Tinea Pedis Treatment Competition Analysis by Players
2.1 Tinea Pedis Treatment Market Size (Value) by Players (2013-2018)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 GSK
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Tinea Pedis Treatment Revenue (Million USD) (2013-2018)
3.1.5 Recent Developments
3.2 Exeltis USA
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Tinea Pedis Treatment Revenue (Million USD) (2013-2018)
3.2.5 Recent Developments
3.3 Promius Pharma
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Tinea Pedis Treatment Revenue (Million USD) (2013-2018)
3.3.5 Recent Developments
3.4 Valeant
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Tinea Pedis Treatment Revenue (Million USD) (2013-2018)
3.4.5 Recent Developments
3.5 Incyte
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Tinea Pedis Treatment Revenue (Million USD) (2013-2018)
3.5.5 Recent Developments
3.6 Polichem
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Tinea Pedis Treatment Revenue (Million USD) (2013-2018)
3.6.5 Recent Developments
3.7 Viamet Pharmaceuticals
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Tinea Pedis Treatment Revenue (Million USD) (2013-2018)
3.7.5 Recent Developments
3.8 Aqua Pharmaceuticals
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Tinea Pedis Treatment Revenue (Million USD) (2013-2018)
3.8.5 Recent Developments
3.9 Theravance Biopharma
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Tinea Pedis Treatment Revenue (Million USD) (2013-2018)
3.9.5 Recent Developments
3.10 Bristol-Myers Squibb
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Tinea Pedis Treatment Revenue (Million USD) (2013-2018)
3.10.5 Recent Developments
3.11 Celgene
3.12 Hexima
3.13 Hisamitsu Pharmaceutical
3.14 Dermira
3.15 NovaBiotics
3.16 Elorac
3.17 F. Hoffmann-La Roche
3.18 Galderma
3.19 Mayne Pharma
3.20 Sanofi
3.21 Teva Pharmaceutical
4 Global Tinea Pedis Treatment Market Size by Type and Application (2013-2018)
4.1 Global Tinea Pedis Treatment Market Size by Type (2013-2018)
4.2 Global Tinea Pedis Treatment Market Size by Application (2013-2018)
4.3 Potential Application of Tinea Pedis Treatment in Future
4.4 Top Consumer/End Users of Tinea Pedis Treatment
5 United States Tinea Pedis Treatment Development Status and Outlook
5.1 United States Tinea Pedis Treatment Market Size (2013-2018)
5.2 United States Tinea Pedis Treatment Market Size and Market Share by Players (2013-2018)
5.3 United States Tinea Pedis Treatment Market Size by Application (2013-2018)
6 EU Tinea Pedis Treatment Development Status and Outlook
6.1 EU Tinea Pedis Treatment Market Size (2013-2018)
6.2 EU Tinea Pedis Treatment Market Size and Market Share by Players (2013-2018)
6.3 EU Tinea Pedis Treatment Market Size by Application (2013-2018)
7 Japan Tinea Pedis Treatment Development Status and Outlook
7.1 Japan Tinea Pedis Treatment Market Size (2013-2018)
7.2 Japan Tinea Pedis Treatment Market Size and Market Share by Players (2013-2018)
7.3 Japan Tinea Pedis Treatment Market Size by Application (2013-2018)
8 China Tinea Pedis Treatment Development Status and Outlook
8.1 China Tinea Pedis Treatment Market Size (2013-2018)
8.2 China Tinea Pedis Treatment Market Size and Market Share by Players (2013-2018)
8.3 China Tinea Pedis Treatment Market Size by Application (2013-2018)
9 India Tinea Pedis Treatment Development Status and Outlook
9.1 India Tinea Pedis Treatment Market Size (2013-2018)
9.2 India Tinea Pedis Treatment Market Size and Market Share by Players (2013-2018)
9.3 India Tinea Pedis Treatment Market Size by Application (2013-2018)
10 Southeast Asia Tinea Pedis Treatment Development Status and Outlook
10.1 Southeast Asia Tinea Pedis Treatment Market Size (2013-2018)
10.2 Southeast Asia Tinea Pedis Treatment Market Size and Market Share by Players (2013-2018)
10.3 Southeast Asia Tinea Pedis Treatment Market Size by Application (2013-2018)
11 Market Forecast by Regions, Type and Application (2018-2025)
11.1 Global Tinea Pedis Treatment Market Size (Value) by Regions (2018-2025)
11.1.1 United States Tinea Pedis Treatment Revenue and Growth Rate (2018-2025)
11.1.2 EU Tinea Pedis Treatment Revenue and Growth Rate (2018-2025)
11.1.3 Japan Tinea Pedis Treatment Revenue and Growth Rate (2018-2025)
11.1.4 China Tinea Pedis Treatment Revenue and Growth Rate (2018-2025)
11.1.5 India Tinea Pedis Treatment Revenue and Growth Rate (2018-2025)
11.1.6 Southeast Asia Tinea Pedis Treatment Revenue and Growth Rate (2018-2025)
11.2 Global Tinea Pedis Treatment Market Size (Value) by Type (2018-2025)
11.3 Global Tinea Pedis Treatment Market Size by Application (2018-2025)
12 Tinea Pedis Treatment Market Dynamics
12.1 Tinea Pedis Treatment Market Opportunities
12.2 Tinea Pedis Treatment Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Tinea Pedis Treatment Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Tinea Pedis Treatment Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 Research Finding/Conclusion
15 Appendix
Methodology
Analyst Introduction
Data Source
List of Tables and Figures
Figure Global Tinea Pedis Treatment Market Size (Million USD) Status and Outlook (2013-2018)
Table Global Tinea Pedis Treatment Revenue (Million USD) Comparison by Regions (2013-2018)
Figure Global Tinea Pedis Treatment Market Share by Regions (2013-2018)
Figure United States Tinea Pedis Treatment Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure EU Tinea Pedis Treatment Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Japan Tinea Pedis Treatment Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure China Tinea Pedis Treatment Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure India Tinea Pedis Treatment Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Southeast Asia Tinea Pedis Treatment Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Table Global Tinea Pedis Treatment Revenue (Million USD) and Growth Rate (%) Comparison by Product (2013-2018)
Figure Global Tinea Pedis Treatment Revenue Market Share by Type in 2017
Figure Antifungals Market Size (Million USD) and Growth Rate (2013-2018)
Figure Steroids and Anti-Infective Combinations Market Size (Million USD) and Growth Rate (2013-2018)
Figure Global Tinea Pedis Treatment Market Share by Application in 2017
Figure Tinea Pedis Treatment Market Size (Million USD) and Growth Rate in Hospital Pharmacies (2013-2018)
Figure Tinea Pedis Treatment Market Size (Million USD) and Growth Rate in Retail Pharmacies (2013-2018)
Figure Tinea Pedis Treatment Market Size (Million USD) and Growth Rate in Online Pharmacies (2013-2018)
Figure Tinea Pedis Treatment Market Size (Million USD) and Growth Rate in Drug Stores (2013-2018)
Figure Tinea Pedis Treatment Market Size (Million USD) and Growth Rate in Other (2013-2018)
Table Tinea Pedis Treatment Market Size (Million USD) by Players (2013-2018)
Figure Tinea Pedis Treatment Market Size Share by Players in 2013
Figure Tinea Pedis Treatment Market Size Share by Players in 2017
Table GSK Basic Information List
Table Tinea Pedis Treatment Business Revenue (Million USD) of GSK (2013-2018)
Figure GSK Tinea Pedis Treatment Business Revenue Market Share (2013-2018)
Table Exeltis USA Basic Information List
Table Tinea Pedis Treatment Business Revenue (Million USD) of Exeltis USA (2013-2018)
Figure Exeltis USA Tinea Pedis Treatment Business Revenue Market Share (2013-2018)
Table Promius Pharma Basic Information List
Table Tinea Pedis Treatment Business Revenue (Million USD) of Promius Pharma (2013-2018)
Figure Promius Pharma Tinea Pedis Treatment Business Revenue Market Share (2013-2018)
Table Valeant Basic Information List
Table Tinea Pedis Treatment Business Revenue (Million USD) of Valeant (2013-2018)
Figure Valeant Tinea Pedis Treatment Business Revenue Market Share (2013-2018)
Table Incyte Basic Information List
Table Tinea Pedis Treatment Business Revenue (Million USD) of Incyte (2013-2018)
Figure Incyte Tinea Pedis Treatment Business Revenue Market Share (2013-2018)
Table Polichem Basic Information List
Table Tinea Pedis Treatment Business Revenue (Million USD) of Polichem (2013-2018)
Figure Polichem Tinea Pedis Treatment Business Revenue Market Share (2013-2018)
Table Viamet Pharmaceuticals Basic Information List
Table Tinea Pedis Treatment Business Revenue (Million USD) of Viamet Pharmaceuticals (2013-2018)
Figure Viamet Pharmaceuticals Tinea Pedis Treatment Business Revenue Market Share (2013-2018)
Table Aqua Pharmaceuticals Basic Information List
Table Tinea Pedis Treatment Business Revenue (Million USD) of Aqua Pharmaceuticals (2013-2018)
Figure Aqua Pharmaceuticals Tinea Pedis Treatment Business Revenue Market Share (2013-2018)
Table Theravance Biopharma Basic Information List
Table Tinea Pedis Treatment Business Revenue (Million USD) of Theravance Biopharma (2013-2018)
Figure Theravance Biopharma Tinea Pedis Treatment Business Revenue Market Share (2013-2018)
Table Bristol-Myers Squibb Basic Information List
Table Tinea Pedis Treatment Business Revenue (Million USD) of Bristol-Myers Squibb (2013-2018)
Figure Bristol-Myers Squibb Tinea Pedis Treatment Business Revenue Market Share (2013-2018)
Table Celgene Basic Information List
Table Tinea Pedis Treatment Business Revenue (Million USD) of Celgene (2013-2018)
Figure Celgene Tinea Pedis Treatment Business Revenue Market Share (2013-2018)
Table Hexima Basic Information List
Table Tinea Pedis Treatment Business Revenue (Million USD) of Hexima (2013-2018)
Figure Hexima Tinea Pedis Treatment Business Revenue Market Share (2013-2018)
Table Hisamitsu Pharmaceutical Basic Information List
Table Tinea Pedis Treatment Business Revenue (Million USD) of Hisamitsu Pharmaceutical (2013-2018)
Figure Hisamitsu Pharmaceutical Tinea Pedis Treatment Business Revenue Market Share (2013-2018)
Table Dermira Basic Information List
Table Tinea Pedis Treatment Business Revenue (Million USD) of Dermira (2013-2018)
Figure Dermira Tinea Pedis Treatment Business Revenue Market Share (2013-2018)
Table NovaBiotics Basic Information List
Table Tinea Pedis Treatment Business Revenue (Million USD) of NovaBiotics (2013-2018)
Figure NovaBiotics Tinea Pedis Treatment Business Revenue Market Share (2013-2018)
Table Elorac Basic Information List
Table Tinea Pedis Treatment Business Revenue (Million USD) of Elorac (2013-2018)
Figure Elorac Tinea Pedis Treatment Business Revenue Market Share (2013-2018)
Table F. Hoffmann-La Roche Basic Information List
Table Tinea Pedis Treatment Business Revenue (Million USD) of F. Hoffmann-La Roche (2013-2018)
Figure F. Hoffmann-La Roche Tinea Pedis Treatment Business Revenue Market Share (2013-2018)
Table Galderma Basic Information List
Table Tinea Pedis Treatment Business Revenue (Million USD) of Galderma (2013-2018)
Figure Galderma Tinea Pedis Treatment Business Revenue Market Share (2013-2018)
Table Mayne Pharma Basic Information List
Table Tinea Pedis Treatment Business Revenue (Million USD) of Mayne Pharma (2013-2018)
Figure Mayne Pharma Tinea Pedis Treatment Business Revenue Market Share (2013-2018)
Table Sanofi Basic Information List
Table Tinea Pedis Treatment Business Revenue (Million USD) of Sanofi (2013-2018)
Figure Sanofi Tinea Pedis Treatment Business Revenue Market Share (2013-2018)
Table Teva Pharmaceutical Basic Information List
Table Tinea Pedis Treatment Business Revenue (Million USD) of Teva Pharmaceutical (2013-2018)
Figure Teva Pharmaceutical Tinea Pedis Treatment Business Revenue Market Share (2013-2018)
Table Global Tinea Pedis Treatment Market Size (Million USD) by Product (2013-2018)
Figure Global Tinea Pedis Treatment Revenue Market Share (%) by Product (2013-2018)
Figure Global Tinea Pedis Treatment Market Share by Product in 2017
Table Global Tinea Pedis Treatment Market Size by Application (2013-2018)
Figure Global Tinea Pedis Treatment Revenue Market Share (%) by Application in 2017
Table Top Consumer/End Users of Tinea Pedis Treatment
Figure United States Tinea Pedis Treatment Market Size (Million USD) and Growth Rate (2013-2018)
Table United States Tinea Pedis Treatment Market Size (Million USD) by Players (2013-2018)
Figure United States Tinea Pedis Treatment Market Size Share by Players in 2013
Figure United States Tinea Pedis Treatment Market Size Share by Players in 2017
Table United States Tinea Pedis Treatment Market Size by Application (2013-2018)
Figure United States Tinea Pedis Treatment Revenue Market Share (%) by Application (2013-2018)
Figure United States Tinea Pedis Treatment Market Size Share by Application in 2017
Figure EU Tinea Pedis Treatment Market Size (Million USD) and Growth Rate (2013-2018)
Table EU Tinea Pedis Treatment Market Size (Million USD) by Players (2013-2018)
Figure EU Tinea Pedis Treatment Market Size Share by Players in 2013
Figure EU Tinea Pedis Treatment Market Size Share by Players in 2017
Table EU Tinea Pedis Treatment Market Size by Application (2013-2018)
Figure EU Tinea Pedis Treatment Revenue Market Share (%) by Application (2013-2018)
Figure EU Tinea Pedis Treatment Market Size Share by Application in 2017
Figure Japan Tinea Pedis Treatment Market Size (Million USD) and Growth Rate (2013-2018)
Table Japan Tinea Pedis Treatment Market Size (Million USD) by Players (2013-2018)
Figure Japan Tinea Pedis Treatment Market Size Share by Players in 2013
Figure Japan Tinea Pedis Treatment Market Size Share by Players in 2017
Table Japan Tinea Pedis Treatment Market Size by Application (2013-2018)
Figure Japan Tinea Pedis Treatment Revenue Market Share (%) by Application (2013-2018)
Figure Japan Tinea Pedis Treatment Market Size Share by Application in 2017
Figure China Tinea Pedis Treatment Market Size (Million USD) and Growth Rate (2013-2018)
Table China Tinea Pedis Treatment Market Size (Million USD) by Players (2013-2018)
Figure China Tinea Pedis Treatment Market Size Share by Players in 2013
Figure China Tinea Pedis Treatment Market Size Share by Players in 2017
Table China Tinea Pedis Treatment Market Size by Application (2013-2018)
Figure China Tinea Pedis Treatment Revenue Market Share (%) by Application (2013-2018)
Figure China Tinea Pedis Treatment Market Size Share by Application in 2017
Figure India Tinea Pedis Treatment Market Size (Million USD) and Growth Rate (2013-2018)
Table India Tinea Pedis Treatment Market Size (Million USD) by Players (2013-2018)
Figure India Tinea Pedis Treatment Market Size Share by Players in 2013
Figure India Tinea Pedis Treatment Market Size Share by Players in 2017
Table India Tinea Pedis Treatment Market Size by Application (2013-2018)
Figure India Tinea Pedis Treatment Revenue Market Share (%) by Application (2013-2018)
Figure India Tinea Pedis Treatment Market Size Share by Application in 2017
Figure Southeast Asia Tinea Pedis Treatment Market Size (Million USD) and Growth Rate (2013-2018)
Table Southeast Asia Tinea Pedis Treatment Market Size (Million USD) by Players (2013-2018)
Figure Southeast Asia Tinea Pedis Treatment Market Size Share by Players in 2013
Figure Southeast Asia Tinea Pedis Treatment Market Size Share by Players in 2017
Table Southeast Asia Tinea Pedis Treatment Market Size by Application (2013-2018)
Figure Southeast Asia Tinea Pedis Treatment Revenue Market Share (%) by Application (2013-2018)
Figure Southeast Asia Tinea Pedis Treatment Market Size Share by Application in 2017
Figure Global Tinea Pedis Treatment Market Size and Growth Rate (2018-2025)
Table Global Tinea Pedis Treatment Market Size (Million USD) by Regions (2018-2025)
Figure Global Tinea Pedis Treatment Market Size Share (2018-2025)
Figure Global Tinea Pedis Treatment Market Size Share by Regions in 2025
Figure United States Tinea Pedis Treatment Revenue (Million USD) and Growth Rate (2018-2025)
Figure EU Tinea Pedis Treatment Revenue (Million USD) and Growth Rate (2018-2025)
Figure Japan Tinea Pedis Treatment Revenue (Million USD) and Growth Rate (2018-2025)
Figure China Tinea Pedis Treatment Revenue (Million USD) and Growth Rate (2018-2025)
Figure India Tinea Pedis Treatment Revenue (Million USD) and Growth Rate (2018-2025)
Figure Southeast Asia Tinea Pedis Treatment Revenue (Million USD) and Growth Rate (2018-2025)
Table Global Tinea Pedis Treatment Market Size (Million USD) by Type (2018-2025)
Figure Global Tinea Pedis Treatment Market Size Share by Type in 2018
Figure Global Tinea Pedis Treatment Market Size Share by Type in 2025
Table Global Tinea Pedis Treatment Market Size (Million USD) by Application (2018-2025)
Figure Global Tinea Pedis Treatment Market Size (Million USD) by Application in 2018
Figure Global Tinea Pedis Treatment Market Size (Million USD) by Application in 2025
  • Global Viscosupplementation Market Size, Status and Forecast 2025
    Published: 05-Apr-2018        Price: US 3300 Onwards        Pages: 93
    This report studies the global Viscosupplementation market, analyzes and researches the Viscosupplementation development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Sanofi - Anika Therapeutics, Inc. - Seikagaku Corporation - Zimmer Holdings Inc - Bioventus - Ferring B.V. - Lifecore Biomedical, LLC - LG Life Sciences Ltd Marke......
  • Global Arthritis Partnering 2012 to 2018
    Published: 01-Apr-2018        Price: US 1995 Onwards        Pages: 200
    "Delivery of this report will take 1-3 days after purchase." Summary The Global Arthritis Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals by value - Deals listed by company A-Z, industry sector, stage of development, technology type The report......
  • Global Rheumatoid Arthritis Partnering 2012 to 2018
    Published: 01-Apr-2018        Price: US 1995 Onwards        Pages: 200
    "Delivery of this report will take 1-3 days after purchase." Summary The Global Rheumatoid Arthritis Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals by value - Deals listed by company A-Z, industry sector, stage of development, technology type ......
  • Global Osteoarthritis Partnering 2012 to 2018
    Published: 01-Apr-2018        Price: US 1995 Onwards        Pages: 100
    "Delivery of this report will take 1-3 days after purchase." Summary The Global Osteoarthritis Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals by value - Deals listed by company A-Z, industry sector, stage of development, technology type The r......
  • Rheumatoid Arthritis Therapeutics in Asia-Pacific Markets to 2023 - Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs
    Published: 01-Mar-2018        Price: US 4995 Onwards        Pages: 148
    Summary Rheumatoid Arthritis (RA) is a chronic, progressive and currently incurable autoimmune disease that primarily affects the joints. It is characterized by synovial inflammation and gradual bone erosion over many years. Disease progression results in stiffness and pain, especially in the hands and feet, which hinders mobility. Without treatment, the disease leads to joint destruction and disability. The chronic nature of the disease, which requires ongoin......
  • Osteoarthritis - Pipeline Review, H1 2018
    Published: 20-Feb-2018        Price: US 2000 Onwards        Pages: 240
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteoarthritis - Pipeline Review, H1 2018, provides an overview of the Osteoarthritis (Musculoskeletal Disorders) pipeline landscape. Osteoarthritis (OA) is one of the most common forms of arthritis. It is a chronic condition in which the cartilage breaks down. Symptoms of osteoarthritis include sore or stiff joints, pain that is worse after activity, bone spurs and grating sensation. Risk factors ......
  • Systemic Juvenile Idiopathic Arthritis (SJIA) - Global API Manufacturers, Marketed and Phase III Drugs Landscape
    Published: 31-Jan-2018        Price: US 2000 Onwards        Pages: 60
    Introduction DelveInsight's, "Systemic Juvenile Idiopathic Arthritis (SJIA) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018" report provides comprehensive insights about marketed and Phase III products for Systemic Juvenile Idiopathic Arthritis (SJIA) . The report includes information of marketed products including their product description, patent details, forecasted sales till 2020 & API manufacturer details by country. Global API Manufac......
  • Systemic Juvenile Idiopathic Arthritis (SJIA) - Epidemiology Forecast to 2027
    Published: 31-Jan-2018        Price: US 3250 Onwards        Pages: 50
    DelveInsight's "Systemic Juvenile Idiopathic Arthritis (SJIA) - Epidemiology Forecast, 2027" report provides a comprehensive analysis of the Systemic Juvenile Idiopathic Arthritis (SJIA) epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2027. Markets Covered - United States - EU5 (Germany, France, Italy, Spain, and the United Kingdom) - Japan Study Period: 2016-2027 Systemi......
  • Juvenile Rheumatoid Arthritis - Market Insight, Epidemiology and Market Forecast - 2027
    Published: 31-Jan-2018        Price: US 6250 Onwards        Pages: 100
    DelveInsight's "Juvenile Rheumatoid Arthritis - Market Insight, Epidemiology and Market Forecast - 2027" report provides a detailed analysis of the Juvenile Rheumatoid Arthritis epidemiology and market outlook for the 7MM. Markets Covered - United States - EU5 (Germany, France, Italy, Spain, and the United Kingdom) - Japan Study Period: 2016-2027 Juvenile Rheumatoid Arthritis Understanding and Treatment Algorithm The market......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs